{
  "claim_id": "claim_002",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "document": "CDC_Influenza_vaccines",
  "verification_stats": {
    "total_extracted": 0,
    "verified": 0,
    "rejected": 0,
    "verification_rate": 0
  },
  "verified_evidence": [],
  "rejected_evidence": [],
  "model_used": "gpt-4.1"
}